Washington: A new blood test that is 96 percent accurate at identifying Alzheimer’s disease and can perhaps detect it even before symptoms such as memory loss, poor judgment or erratic behaviour appear has been developed by scientists from Durin Technologies, Inc., and the University of Medicine and Dentistry of New Jersey (UMDNJ)-School of Osteopathic Medicine. The test that uses human protein microarrays to detect the presence of specific antibodies in the blood has a specificity of 92.5 percent and has the potential to spot Alzheimer’s in its earliest stages. The same test also demonstrated the ability to distinguish Alzheimer’s from Parkinson’s disease, a closely related neurodegenerative disorder.“A test that can not only diagnose the disease in individuals showing telltale symptoms, but possibly also detect the disease years before these symptoms appear would make early therapeutic intervention possible. This would be a significant breakthrough as pharmaceutical companies are now working feverishly to develop new drugs that can stop or slow the progression of Alzheimer’s,” said Robert Nagele, PhD, founder of Durin Technologies, Inc., and a professor at the UMDNJ-School of Osteopathic Medicine.
Complete analysis of Modi govt`s maiden budget
Budget growth oriented, says Arun Jaitley
Acting legend Zohra Sehgal dies at 102
We didn`t want to burden the common man: Arun Jaitley on budget